Assessment of outcomes of allogeneic stem cell transplantation by treatment arm in newly diagnosed measurable residual disease negative patients with B-lineage acute lymphoblastic leukemia randomized to conventional chemotherapy +/- blinatumomab in the ECOG-ACRIN E1910 phase III National Clinical Trials Network trial Meeting Abstract
| Authors: | Liedtke, M.; Sun, Z.; Litzow, M. R.; Mattison, R. J.; Paietta, E.; Roberts, K. G.; Zhang, Y.; Racevskis, J.; Lazarus, H. M.; Rowe, J. M.; Arber, D. A.; Bergeron, J.; Wood, B. L.; Zhao, Y.; Wu, G.; Chang, T. C.; Zhang, W.; Pratz, K. W.; Dinner, S. N.; Frey, N.; Gore, S. D.; Bhatnagar, B.; Atallah, E. L.; Uy, G. L.; Jeyakumar, D.; Lin, T. L.; Willman, C. L.; DeAngelo, D. J.; Patel, S. B.; Elliott, M. A.; Advani, A. S.; Tzachanis, D.; Vachhani, P.; Bhave, R.; Sharon, E.; Little, R.; Erba, H. P.; Stone, R. M.; Luger, S.; Mullighan, C. G.; Tallman, M. S.; Wieduwilt, M. J. |
| Abstract Title: | Assessment of outcomes of allogeneic stem cell transplantation by treatment arm in newly diagnosed measurable residual disease negative patients with B-lineage acute lymphoblastic leukemia randomized to conventional chemotherapy +/- blinatumomab in the ECOG-ACRIN E1910 phase III National Clinical Trials Network trial |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 779 |
| End Page: | 781 |
| Language: | English |
| ACCESSION: | WOS:001412816800029 |
| DOI: | 10.1182/blood-2024-207557 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
